USD 3.41
(3.33%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 9.23 Million USD | 180.44% |
2022 | 9.24 Million USD | -266.15% |
2021 | 35.97 Million USD | 5.06% |
2020 | 32.91 Million USD | 35.48% |
2019 | 24.29 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 7.49 Million USD | -648.58% |
2024 Q1 | 11.17 Million USD | -107.38% |
2023 Q2 | 9.09 Million USD | -1.03% |
2023 FY | - USD | 180.44% |
2023 Q3 | 8.01 Million USD | -11.93% |
2023 Q1 | 9.19 Million USD | 16.03% |
2023 Q4 | 11.57 Million USD | 44.52% |
2022 Q2 | -76.18 Million USD | -841.47% |
2022 Q1 | 10.27 Million USD | 73.3% |
2022 FY | - USD | -266.15% |
2022 Q4 | 7.92 Million USD | -9.47% |
2022 Q3 | 8.75 Million USD | 111.49% |
2021 Q4 | 5.92 Million USD | -36.38% |
2021 Q2 | 10.26 Million USD | 7.27% |
2021 Q1 | 9.56 Million USD | -5.63% |
2021 FY | - USD | 5.06% |
2021 Q3 | 9.32 Million USD | -9.2% |
2020 Q4 | 10.13 Million USD | 0.0% |
2020 FY | - USD | 35.48% |
2019 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 189.11 Million USD | 95.117% |
Addus HomeCare Corporation | 106.55 Million USD | 91.334% |
AirSculpt Technologies, Inc. | 28.31 Million USD | 67.385% |
Amedisys, Inc. | 216.91 Million USD | 95.743% |
American Oncology Network, Inc. | -39.35 Million USD | 123.466% |
Astrana Health, Inc. | 123.68 Million USD | 92.534% |
Aveanna Healthcare Holdings Inc. | 44.34 Million USD | 79.178% |
IMAC Holdings, Inc. | -5.94 Million USD | 255.277% |
Cryo-Cell International, Inc. | -10.41 Million USD | 188.641% |
Cross Country Healthcare, Inc. | 129.33 Million USD | 92.86% |
COMPASS Pathways plc | -123.8 Million USD | 107.459% |
DocGo Inc. | 32.72 Million USD | 71.783% |
The Ensign Group, Inc. | 353.23 Million USD | 97.386% |
Healthcare Services Group, Inc. | 75.21 Million USD | 87.723% |
InnovAge Holding Corp. | 1.15 Million USD | -700.173% |
Assure Holdings Corp. | -19.82 Million USD | 146.58% |
The Joint Corp. | 9.14 Million USD | -1.009% |
LifeStance Health Group, Inc. | -104.92 Million USD | 108.8% |
Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | 159.365% |
ModivCare Inc. | -26.75 Million USD | 134.52% |
NewGenIvf Group Limited | 384.3 Thousand USD | -2302.779% |
Novo Integrated Sciences, Inc. | -5.84 Million USD | 257.873% |
Option Care Health, Inc. | 376.79 Million USD | 97.549% |
P3 Health Partners Inc. | -81.07 Million USD | 111.39% |
P3 Health Partners Inc. | -81.07 Million USD | 111.39% |
The Pennant Group, Inc. | 30.36 Million USD | 69.594% |
Surgery Partners, Inc. | 446.1 Million USD | 97.93% |
Syra Health Corp. Class A Common Stock | -2.83 Million USD | 425.613% |
Talkspace, Inc. | -22.01 Million USD | 141.948% |
Talkspace, Inc. | -22.01 Million USD | 141.948% |
The Oncology Institute, Inc. | -70.45 Million USD | 113.106% |
The Oncology Institute, Inc. | -70.45 Million USD | 113.106% |